Related Experiment Video

Updated: Jun 16, 2026

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
11:04

An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model

Published on: January 13, 2023

Towards characteristics of photodynamic drugs specifically aimed at microvascular diseases

Jingquan Zhao1, Hong Deng, Jie Xie

  • 1Beijing National Laboratory for Molecular Sciences (BNLMS), Key Laboratory of Photochemistry, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, PR China. zhaojq@iccas.ac.cn

Mini Reviews in Medicinal Chemistry
|January 29, 2010
PubMed

Insights

Perilenoquinoid photosensitizers show potential for treating microvascular and superficial diseases with photodynamic therapy (PDT). Strategies are discussed to improve drug delivery and biological activity for clinical applications.

Area of Science:

  • Photochemistry
  • Biomedical Engineering
  • Dermatology

Background:

  • Photodynamic therapy (PDT) offers versatile disease treatment but requires tailored photosensitizers.
  • Perilenoquinoid photosensitizers have limitations for solid tumors due to poor absorption in the photodynamic window.
  • These compounds may be suitable for specific microvascular diseases like age-related macular degeneration (AMD) and port wine stains (PWS).

Purpose of the Study:

  • To explore the potential of perilenoquinoid photosensitizers for specific PDT applications.
  • To address the need for photosensitizers with improved efficacy for certain diseases.
  • To investigate strategies for developing clinically viable photosensitizer drugs.

Main Methods:

  • Review of perilenoquinoid photosensitizer properties.
  • Analysis of absorption characteristics within the photodynamic window.
  • Discussion of drug-delivery and biological activity enhancement strategies.

Main Results:

  • Perilenoquinoid photosensitizers exhibit limited effectiveness for solid tumors.
  • These photosensitizers show promise for treating superficial and microvascular conditions.
  • Two key strategies for clinical drug development were identified.

Conclusions:

  • Perilenoquinoid photosensitizers are not ideal for solid tumors but have therapeutic potential for AMD, PWS, and other superficial diseases.
  • Further research into drug delivery and biological activity is crucial for clinical translation.
  • Tailored photosensitizers are essential for optimizing photodynamic therapy outcomes.

More Related Videos

In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology13:17

In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology

Published on: September 29, 2023

Osmotic Drug Delivery to Ischemic Hindlimbs and Perfusion of Vasculature with Microfil for Micro-Computed Tomography Imaging10:50

Osmotic Drug Delivery to Ischemic Hindlimbs and Perfusion of Vasculature with Microfil for Micro-Computed Tomography Imaging

Published on: June 29, 2013

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...